Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T39110 |
MOG (35-55), human
|
||
MOG (35-55), human, a constituent of central nervous system myelin, is distinguishable from mMOG (35-55) due to a proline-to-serine substitution at position 42. It possesses immunogenic properties and is partially cross-reactive with mMOG35–55. However, MOG (35-55), human does not induce encephalitogenic effects, and only elicits minimal clinical signs of EAE (experimental autoimmune encephalomyelitis) in comparison to the rodent peptide. | |||
T39671 |
MOG (89-113), human
|
||
MOG (89-113), human is a peptide fragment of human myelin oligodendrocyte glycoprotein. |